Pages that link to "Q73459534"
Jump to navigation
Jump to search
The following pages link to Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers (Q73459534):
Displaying 50 items.
- International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states (Q24643524) (← links)
- Prostate cancer relevant antigens and enzymes for targeted drug delivery (Q27013843) (← links)
- Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells (Q33957249) (← links)
- Peptide analogs in the therapy of prostate cancer. (Q34057795) (← links)
- Personalized medicine for the management of benign prostatic hyperplasia (Q34084593) (← links)
- GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells (Q34157062) (← links)
- The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer (Q34224909) (← links)
- Autocrine and paracrine signaling through neuropeptide receptors in human cancer (Q34225976) (← links)
- Hypothalamic hormones and cancer (Q34392227) (← links)
- Evolution of bombesin conjugates for targeted PET imaging of tumors (Q34424982) (← links)
- Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma (Q34478021) (← links)
- Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging (Q34752361) (← links)
- New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin (Q35086080) (← links)
- Design and Synthesis of a Bombesin Peptide-Conjugated Tripodal Phosphino Dithioether Ligand Topology for the Stabilization of the fac-[M(CO)3] Core (M = 99 mTc or Re) (Q35609666) (← links)
- Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update (Q35617885) (← links)
- Chemotherapy targeted to cancers through tumoral hormone receptors (Q35879365) (← links)
- Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells (Q36233076) (← links)
- Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist (Q36617058) (← links)
- Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists (Q36642293) (← links)
- Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones (Q36912988) (← links)
- New treatment approaches for prostate cancer based on peptide analogues (Q37059390) (← links)
- Targeting GRPR in urological cancers--from basic research to clinical application (Q38090926) (← links)
- Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment (Q38776596) (← links)
- Discovery of LHRH and development of LHRH analogs for prostate cancer treatment (Q39267156) (← links)
- New aspects of molecular imaging in prostate cancer. (Q39437137) (← links)
- Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours (Q39666421) (← links)
- Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours (Q40173304) (← links)
- Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas (Q40364429) (← links)
- Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. (Q40449157) (← links)
- Transcriptional activation of the human gastrin-releasing peptide receptor gene in gastrointestinal and prostatic epithelial cancer cells (Q40535794) (← links)
- Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD (Q42324524) (← links)
- Protein-based MRI contrast agents for molecular imaging of prostate cancer. (Q42530455) (← links)
- Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model (Q42876685) (← links)
- Characterization of the bombesin-like peptide receptor family in primates. (Q47328257) (← links)
- Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells (Q47746078) (← links)
- Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors (Q48096316) (← links)
- Gastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells. (Q48969607) (← links)
- Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. (Q53375809) (← links)
- Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers. (Q54655043) (← links)
- Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215. (Q54674276) (← links)
- 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study (Q56516407) (← links)
- The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I) (Q58585681) (← links)
- Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies (Q60727900) (← links)
- In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215 (Q73141867) (← links)
- Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer (Q73622046) (← links)
- In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors (Q74379400) (← links)
- Genetic identification of multiple susceptibility genes involved in the development of endometrial carcinoma in a rat model (Q77357807) (← links)
- Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients (Q77926680) (← links)
- Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer (Q92150257) (← links)
- Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy (Q92572055) (← links)